Monday, May 28, 2018
Honey-Based Gel May Help Treat Skin, Ear Infections in Dogs
In vitro efficacy of a honey‐based gel against canine clinical isolates of Staphylococcus pseudintermedius and Malassezia pachydermatis
BUY Concentrated Propolis in Veggie Capsules
Veterinary Dermatology
Volume 29, Issue 3, June 2018, Pages 180-e65
Background
Staphylococcus pseudintermedius and Malassezia pachydermatis are important agents in canine pyoderma and otitis.
Hypothesis/Objectives
Determine the in vitro efficacy of a honey‐based gel (HBO) against meticillin‐susceptible S. pseudintermedius (MSSP), meticillin‐resistant S. pseudintermedius (MRSP) and M. pachydermatis, by minimum bactericidal concentration (MBC), minimum fungicidal concentration (MFC) and time‐kill assay (TKA). Efficacy of the product's honey component (HO) also was evaluated.
Methods
Sixty S. pseudintermedius and 10 M. pachydermatis canine isolates were selected. All isolates were tested against serial dilutions of an HBO containing 40% HO (40%, 20%, 10%, 5% and 2.5% w/v) and HO alone (undiluted, 40%, 20%, 10%, 5% and 2.5% w/v). Microbroth assay followed by subculture was used to determine MBC and MFC. The same protocol was applied after product exposure to catalase. A well‐diffusion assay for S. pseudintermedius was used to generate inhibition zones. A TKA for 10 isolates of S. pseudintermedius and 10 isolates of M. pachydermatis was performed.
Results
MBC was 20% w/v (5–20% w/v) for HBO and HO. HBO had lower MBC values when compared to HO (P = 0.003). No statistical difference was observed between MSSP/MRSP isolates (HBO P = 0.757, HO P = 0.743). Only HO was affected by catalase (P = 0.015). MFC for HBO was 10% w/v (5–10% w/v) and 40% w/v for HO (20–≥40% w/v). All isolates were killed after 4 h of exposure.
Conclusions and clinical importance
Staphylococcus pseudintermedius and M. pachydermatis are susceptible to the HBO and these results can be used for future clinical trials.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment